nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—PTGS2—autistic disorder	0.757	1	CbGaD
Naproxen—Indomethacin—GLO1—autistic disorder	0.00727	0.435	CrCbGaD
Naproxen—Ibuprofen—BCL2—autistic disorder	0.00212	0.127	CrCbGaD
Naproxen—Nabumetone—PTGS2—autistic disorder	0.00168	0.101	CrCbGaD
Naproxen—Carprofen—PTGS2—autistic disorder	0.0016	0.0959	CrCbGaD
Naproxen—UGT2B7—digestive system—autistic disorder	0.000999	0.0697	CbGeAlD
Naproxen—Suprofen—PTGS2—autistic disorder	0.00099	0.0593	CrCbGaD
Naproxen—Fenoprofen—PTGS2—autistic disorder	0.000853	0.0511	CrCbGaD
Naproxen—UGT1A1—digestive system—autistic disorder	0.00085	0.0592	CbGeAlD
Naproxen—SLCO1A2—forebrain—autistic disorder	0.00082	0.0572	CbGeAlD
Naproxen—SLCO1A2—telencephalon—autistic disorder	0.000754	0.0526	CbGeAlD
Naproxen—PTGS2—mouth—autistic disorder	0.000704	0.0491	CbGeAlD
Naproxen—AKR1C3—cerebellum—autistic disorder	0.000671	0.0468	CbGeAlD
Naproxen—Indomethacin—PTGS2—autistic disorder	0.000629	0.0377	CrCbGaD
Naproxen—SLCO1A2—digestive system—autistic disorder	0.000575	0.0401	CbGeAlD
Naproxen—Flurbiprofen—PTGS2—autistic disorder	0.000557	0.0333	CrCbGaD
Naproxen—AKR1C3—brain—autistic disorder	0.000545	0.038	CbGeAlD
Naproxen—SLC22A6—brain—autistic disorder	0.000542	0.0378	CbGeAlD
Naproxen—Ketoprofen—PTGS2—autistic disorder	0.000504	0.0302	CrCbGaD
Naproxen—Ibuprofen—PTGS2—autistic disorder	0.000496	0.0297	CrCbGaD
Naproxen—SLCO1A2—head—autistic disorder	0.000469	0.0327	CbGeAlD
Naproxen—PTGS1—forebrain—autistic disorder	0.000464	0.0324	CbGeAlD
Naproxen—SLCO1A2—nervous system—autistic disorder	0.000445	0.031	CbGeAlD
Naproxen—PTGS2—forebrain—autistic disorder	0.000444	0.031	CbGeAlD
Naproxen—SLCO1A2—central nervous system—autistic disorder	0.000428	0.0299	CbGeAlD
Naproxen—PTGS1—telencephalon—autistic disorder	0.000427	0.0298	CbGeAlD
Naproxen—SLCO1A2—cerebellum—autistic disorder	0.000419	0.0292	CbGeAlD
Naproxen—PTGS2—telencephalon—autistic disorder	0.000408	0.0285	CbGeAlD
Naproxen—CYP1A2—digestive system—autistic disorder	0.000376	0.0262	CbGeAlD
Naproxen—CYP2C9—digestive system—autistic disorder	0.000357	0.0249	CbGeAlD
Naproxen—SLCO1A2—brain—autistic disorder	0.00034	0.0237	CbGeAlD
Naproxen—ALB—brain—autistic disorder	0.000338	0.0236	CbGeAlD
Naproxen—PTGS1—digestive system—autistic disorder	0.000326	0.0227	CbGeAlD
Naproxen—PTGS2—digestive system—autistic disorder	0.000312	0.0217	CbGeAlD
Naproxen—PTGS1—head—autistic disorder	0.000266	0.0185	CbGeAlD
Naproxen—PTGS2—head—autistic disorder	0.000254	0.0177	CbGeAlD
Naproxen—PTGS1—nervous system—autistic disorder	0.000252	0.0176	CbGeAlD
Naproxen—PTGS1—central nervous system—autistic disorder	0.000243	0.0169	CbGeAlD
Naproxen—PTGS2—nervous system—autistic disorder	0.000241	0.0168	CbGeAlD
Naproxen—CYP2C8—brain—autistic disorder	0.000238	0.0166	CbGeAlD
Naproxen—PTGS2—central nervous system—autistic disorder	0.000232	0.0162	CbGeAlD
Naproxen—PTGS2—cerebellum—autistic disorder	0.000227	0.0158	CbGeAlD
Naproxen—PTGS1—brain—autistic disorder	0.000193	0.0134	CbGeAlD
Naproxen—PTGS2—brain—autistic disorder	0.000184	0.0128	CbGeAlD
Naproxen—CYP1A2—Metabolism—UPB1—autistic disorder	5.46e-05	0.000259	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SLC19A1—autistic disorder	5.44e-05	0.000257	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PLA2G4A—autistic disorder	5.43e-05	0.000257	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GSTM1—autistic disorder	5.43e-05	0.000257	CbGpPWpGaD
Naproxen—ALB—Hemostasis—ITGB3—autistic disorder	5.4e-05	0.000256	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—DHFR—autistic disorder	5.4e-05	0.000256	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—PRKCB—autistic disorder	5.36e-05	0.000254	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ADA—autistic disorder	5.28e-05	0.00025	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	5.28e-05	0.00025	CbGpPWpGaD
Naproxen—ALB—Metabolism—ADA—autistic disorder	5.25e-05	0.000248	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—AVP—autistic disorder	5.25e-05	0.000248	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	5.22e-05	0.000247	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	5.22e-05	0.000247	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GPX1—autistic disorder	5.2e-05	0.000246	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CYP19A1—autistic disorder	5.19e-05	0.000246	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	5.19e-05	0.000246	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—COMT—autistic disorder	5.17e-05	0.000245	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—TPH2—autistic disorder	5.15e-05	0.000244	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GSTP1—autistic disorder	5.15e-05	0.000244	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—MAOA—autistic disorder	5.13e-05	0.000243	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—PIK3CG—autistic disorder	5.13e-05	0.000243	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—APC—autistic disorder	5.13e-05	0.000243	CbGpPWpGaD
Naproxen—PTGS2—Disease—DHFR—autistic disorder	5.12e-05	0.000242	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTM5—autistic disorder	5.08e-05	0.00024	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ASMT—autistic disorder	5.08e-05	0.00024	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—EGF—autistic disorder	5.07e-05	0.00024	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—DPYD—autistic disorder	5.07e-05	0.00024	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CAT—autistic disorder	5.01e-05	0.000237	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	5e-05	0.000237	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	5e-05	0.000236	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	4.97e-05	0.000235	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—POMC—autistic disorder	4.89e-05	0.000231	CbGpPWpGaD
Naproxen—AKR1C3—Disease—PTEN—autistic disorder	4.85e-05	0.00023	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ADSL—autistic disorder	4.84e-05	0.000229	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—COMT—autistic disorder	4.83e-05	0.000228	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—RORA—autistic disorder	4.81e-05	0.000228	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GSTP1—autistic disorder	4.8e-05	0.000227	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—MTHFR—autistic disorder	4.8e-05	0.000227	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—MAOA—autistic disorder	4.79e-05	0.000227	CbGpPWpGaD
Naproxen—ALB—Metabolism—RORA—autistic disorder	4.79e-05	0.000227	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SLC25A12—autistic disorder	4.78e-05	0.000226	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	4.76e-05	0.000225	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—XDH—autistic disorder	4.75e-05	0.000225	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PLA2G4A—autistic disorder	4.73e-05	0.000224	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GSTM1—autistic disorder	4.73e-05	0.000224	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CACNA1C—autistic disorder	4.71e-05	0.000223	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IGF1—autistic disorder	4.7e-05	0.000222	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CAT—autistic disorder	4.67e-05	0.000221	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—STX1A—autistic disorder	4.66e-05	0.000221	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NPAS2—autistic disorder	4.66e-05	0.000221	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PTGS2—autistic disorder	4.66e-05	0.000221	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SLC19A1—autistic disorder	4.65e-05	0.00022	CbGpPWpGaD
Naproxen—PTGS2—Disease—CALCA—autistic disorder	4.61e-05	0.000218	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	4.55e-05	0.000216	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	4.53e-05	0.000215	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GPX1—autistic disorder	4.53e-05	0.000214	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MAOB—autistic disorder	4.51e-05	0.000214	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—TCN2—autistic disorder	4.5e-05	0.000213	CbGpPWpGaD
Naproxen—ALB—Metabolism—MAOB—autistic disorder	4.49e-05	0.000212	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—APOE—autistic disorder	4.47e-05	0.000212	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—SERPINE1—autistic disorder	4.46e-05	0.000211	CbGpPWpGaD
Naproxen—ALB—Hemostasis—PRKCB—autistic disorder	4.42e-05	0.000209	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—MAPK1—autistic disorder	4.42e-05	0.000209	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PLA2G4A—autistic disorder	4.41e-05	0.000209	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GSTM1—autistic disorder	4.41e-05	0.000209	CbGpPWpGaD
Naproxen—ALB—Hemostasis—NOS2—autistic disorder	4.37e-05	0.000207	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ADA—autistic disorder	4.3e-05	0.000203	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—autistic disorder	4.29e-05	0.000203	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—DHFR—autistic disorder	4.29e-05	0.000203	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—APOE—autistic disorder	4.27e-05	0.000202	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	4.27e-05	0.000202	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	4.25e-05	0.000201	CbGpPWpGaD
Naproxen—ALB—Hemostasis—PIK3CG—autistic disorder	4.23e-05	0.0002	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CYP19A1—autistic disorder	4.23e-05	0.0002	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GPX1—autistic disorder	4.23e-05	0.0002	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—TPH2—autistic disorder	4.19e-05	0.000198	CbGpPWpGaD
Naproxen—ALB—Hemostasis—EGF—autistic disorder	4.18e-05	0.000198	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—MTHFR—autistic disorder	4.18e-05	0.000198	CbGpPWpGaD
Naproxen—ALB—Metabolism—TPH2—autistic disorder	4.17e-05	0.000197	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ADSL—autistic disorder	4.14e-05	0.000196	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—DPYD—autistic disorder	4.13e-05	0.000195	CbGpPWpGaD
Naproxen—ALB—Metabolism—DPYD—autistic disorder	4.1e-05	0.000194	CbGpPWpGaD
Naproxen—PTGS2—Disease—PRL—autistic disorder	4.07e-05	0.000193	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	4.07e-05	0.000192	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PTEN—autistic disorder	4.06e-05	0.000192	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—XDH—autistic disorder	4.06e-05	0.000192	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PIK3CG—autistic disorder	4.03e-05	0.000191	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—STX1A—autistic disorder	3.99e-05	0.000189	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NPAS2—autistic disorder	3.99e-05	0.000189	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	3.97e-05	0.000188	CbGpPWpGaD
Naproxen—AKR1C3—Disease—MAPK1—autistic disorder	3.95e-05	0.000187	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—COMT—autistic disorder	3.93e-05	0.000186	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—RORA—autistic disorder	3.92e-05	0.000185	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GSTP1—autistic disorder	3.92e-05	0.000185	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—MAOA—autistic disorder	3.91e-05	0.000185	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—MTHFR—autistic disorder	3.9e-05	0.000185	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—APOE—autistic disorder	3.89e-05	0.000184	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	3.88e-05	0.000183	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IGF1—autistic disorder	3.88e-05	0.000183	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	3.85e-05	0.000182	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—TCN2—autistic disorder	3.85e-05	0.000182	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—POMC—autistic disorder	3.84e-05	0.000182	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CACNA1C—autistic disorder	3.84e-05	0.000182	CbGpPWpGaD
Naproxen—ALB—Metabolism—CACNA1C—autistic disorder	3.81e-05	0.000181	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CAT—autistic disorder	3.81e-05	0.00018	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—POMC—autistic disorder	3.69e-05	0.000175	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SERPINE1—autistic disorder	3.68e-05	0.000174	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ADA—autistic disorder	3.67e-05	0.000174	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MAOB—autistic disorder	3.67e-05	0.000174	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—POMC—autistic disorder	3.67e-05	0.000174	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—APOE—autistic disorder	3.63e-05	0.000172	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	3.63e-05	0.000172	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL2—autistic disorder	3.61e-05	0.000171	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GSTM1—autistic disorder	3.6e-05	0.00017	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PLA2G4A—autistic disorder	3.6e-05	0.00017	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PIK3CG—autistic disorder	3.51e-05	0.000166	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	3.49e-05	0.000165	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—DHFR—autistic disorder	3.49e-05	0.000165	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	3.48e-05	0.000164	CbGpPWpGaD
Naproxen—ALB—Metabolism—DHFR—autistic disorder	3.47e-05	0.000164	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GPX1—autistic disorder	3.45e-05	0.000163	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—TPH2—autistic disorder	3.41e-05	0.000162	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—PTEN—autistic disorder	3.4e-05	0.000161	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CYP19A1—autistic disorder	3.36e-05	0.000159	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—DPYD—autistic disorder	3.36e-05	0.000159	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—RORA—autistic disorder	3.35e-05	0.000158	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—POMC—autistic disorder	3.34e-05	0.000158	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PIK3CG—autistic disorder	3.28e-05	0.000155	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—MTHFR—autistic disorder	3.18e-05	0.00015	CbGpPWpGaD
Naproxen—AKR1C3—Disease—HRAS—autistic disorder	3.17e-05	0.00015	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	3.15e-05	0.000149	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	3.15e-05	0.000149	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MAOB—autistic disorder	3.14e-05	0.000148	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—COMT—autistic disorder	3.12e-05	0.000148	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CACNA1C—autistic disorder	3.12e-05	0.000148	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—POMC—autistic disorder	3.12e-05	0.000148	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GSTP1—autistic disorder	3.11e-05	0.000147	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—MAOA—autistic disorder	3.1e-05	0.000147	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PTGS2—autistic disorder	3.06e-05	0.000145	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6—autistic disorder	3.03e-05	0.000143	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CAT—autistic disorder	3.02e-05	0.000143	CbGpPWpGaD
Naproxen—PTGS2—Disease—MTHFR—autistic disorder	3.01e-05	0.000143	CbGpPWpGaD
Naproxen—PTGS2—Disease—HLA-A—autistic disorder	3.01e-05	0.000142	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	3e-05	0.000142	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.99e-05	0.000141	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IL2—autistic disorder	2.98e-05	0.000141	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—APOE—autistic disorder	2.96e-05	0.00014	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.94e-05	0.000139	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.93e-05	0.000138	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—TPH2—autistic disorder	2.92e-05	0.000138	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—DPYD—autistic disorder	2.87e-05	0.000136	CbGpPWpGaD
Naproxen—PTGS2—Disease—TSC2—autistic disorder	2.87e-05	0.000136	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PLA2G4A—autistic disorder	2.86e-05	0.000135	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GSTM1—autistic disorder	2.86e-05	0.000135	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—DHFR—autistic disorder	2.84e-05	0.000134	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOE—autistic disorder	2.81e-05	0.000133	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MAPK1—autistic disorder	2.76e-05	0.000131	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GPX1—autistic disorder	2.74e-05	0.000129	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP19A1—autistic disorder	2.73e-05	0.000129	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP19A1—autistic disorder	2.72e-05	0.000129	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.7e-05	0.000128	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PIK3CG—autistic disorder	2.67e-05	0.000126	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PTEN—autistic disorder	2.67e-05	0.000126	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CACNA1C—autistic disorder	2.67e-05	0.000126	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PTGS2—autistic disorder	2.67e-05	0.000126	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS2—autistic disorder	2.61e-05	0.000124	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2.57e-05	0.000121	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.57e-05	0.000121	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2.55e-05	0.000121	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—POMC—autistic disorder	2.54e-05	0.00012	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—COMT—autistic disorder	2.54e-05	0.00012	CbGpPWpGaD
Naproxen—PTGS2—Disease—APC—autistic disorder	2.53e-05	0.00012	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTP1—autistic disorder	2.53e-05	0.00012	CbGpPWpGaD
Naproxen—ALB—Metabolism—COMT—autistic disorder	2.53e-05	0.00012	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—MTHFR—autistic disorder	2.52e-05	0.000119	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MAOA—autistic disorder	2.52e-05	0.000119	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTP1—autistic disorder	2.51e-05	0.000119	CbGpPWpGaD
Naproxen—ALB—Metabolism—MAOA—autistic disorder	2.51e-05	0.000119	CbGpPWpGaD
Naproxen—PTGS2—Disease—EGF—autistic disorder	2.5e-05	0.000118	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PTGS2—autistic disorder	2.49e-05	0.000118	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CAT—autistic disorder	2.46e-05	0.000116	CbGpPWpGaD
Naproxen—ALB—Metabolism—CAT—autistic disorder	2.45e-05	0.000116	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—DHFR—autistic disorder	2.43e-05	0.000115	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.39e-05	0.000113	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOE—autistic disorder	2.35e-05	0.000111	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PTEN—autistic disorder	2.33e-05	0.00011	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTM1—autistic disorder	2.32e-05	0.00011	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PLA2G4A—autistic disorder	2.32e-05	0.00011	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTM1—autistic disorder	2.31e-05	0.000109	CbGpPWpGaD
Naproxen—ALB—Metabolism—PLA2G4A—autistic disorder	2.31e-05	0.000109	CbGpPWpGaD
Naproxen—ALB—Hemostasis—MAPK1—autistic disorder	2.28e-05	0.000108	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GPX1—autistic disorder	2.23e-05	0.000105	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP19A1—autistic disorder	2.22e-05	0.000105	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—HRAS—autistic disorder	2.22e-05	0.000105	CbGpPWpGaD
Naproxen—ALB—Metabolism—GPX1—autistic disorder	2.21e-05	0.000105	CbGpPWpGaD
Naproxen—PTGS2—Disease—SERPINE1—autistic disorder	2.2e-05	0.000104	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PTEN—autistic disorder	2.17e-05	0.000103	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—autistic disorder	2.12e-05	0.0001	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PIK3CG—autistic disorder	2.12e-05	0.0001	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2.09e-05	9.88e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—COMT—autistic disorder	2.07e-05	9.79e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTP1—autistic disorder	2.06e-05	9.74e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MTHFR—autistic disorder	2.05e-05	9.72e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MAOA—autistic disorder	2.05e-05	9.72e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.05e-05	9.68e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—MTHFR—autistic disorder	2.04e-05	9.67e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PTGS2—autistic disorder	2.03e-05	9.6e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—POMC—autistic disorder	2.02e-05	9.55e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CAT—autistic disorder	2e-05	9.48e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOE—autistic disorder	1.91e-05	9.05e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOE—autistic disorder	1.9e-05	9e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP19A1—autistic disorder	1.9e-05	9e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PLA2G4A—autistic disorder	1.89e-05	8.95e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTM1—autistic disorder	1.89e-05	8.95e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—HRAS—autistic disorder	1.83e-05	8.66e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GPX1—autistic disorder	1.81e-05	8.57e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.78e-05	8.45e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PTEN—autistic disorder	1.77e-05	8.37e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—COMT—autistic disorder	1.77e-05	8.36e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTP1—autistic disorder	1.76e-05	8.32e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MAOA—autistic disorder	1.75e-05	8.3e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PIK3CG—autistic disorder	1.73e-05	8.17e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PIK3CG—autistic disorder	1.72e-05	8.12e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CAT—autistic disorder	1.71e-05	8.1e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—PTEN—autistic disorder	1.68e-05	7.94e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MTHFR—autistic disorder	1.67e-05	7.91e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—POMC—autistic disorder	1.64e-05	7.77e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—POMC—autistic disorder	1.63e-05	7.73e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PLA2G4A—autistic disorder	1.62e-05	7.65e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTM1—autistic disorder	1.62e-05	7.65e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOE—autistic disorder	1.56e-05	7.37e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GPX1—autistic disorder	1.55e-05	7.33e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MTHFR—autistic disorder	1.43e-05	6.76e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PIK3CG—autistic disorder	1.4e-05	6.65e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PTEN—autistic disorder	1.4e-05	6.65e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—MAPK1—autistic disorder	1.36e-05	6.45e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—POMC—autistic disorder	1.34e-05	6.33e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOE—autistic disorder	1.33e-05	6.29e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PTGS2—autistic disorder	1.31e-05	6.2e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PTGS2—autistic disorder	1.3e-05	6.17e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PIK3CG—autistic disorder	1.2e-05	5.68e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PTEN—autistic disorder	1.14e-05	5.41e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—POMC—autistic disorder	1.14e-05	5.41e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PTEN—autistic disorder	1.14e-05	5.38e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—HRAS—autistic disorder	1.09e-05	5.18e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PTGS2—autistic disorder	1.07e-05	5.05e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—autistic disorder	1.05e-05	4.96e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PTEN—autistic disorder	9.3e-06	4.4e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PTGS2—autistic disorder	9.11e-06	4.31e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PTEN—autistic disorder	7.95e-06	3.76e-05	CbGpPWpGaD
